(11)On 29 September 2020, the Authority published an updated conclusionnote with regard to the endocrine disrupting properties considering the criteria laid down in points 3.6.5 and 3.8.2 of Annex II to Regulation (EC) No 1107/2009, as amended by Regulation (EU) 2018/605. The Commission invited the applicant to submit its comments on the conclusion of the Authority and, in accordance with the third paragraph of Article 17(1) of Regulation (EU) No 1141/2010, on the review report. The applicant submitted its comments, which have been carefully examined.